시장조사 보고서 : 세계의 양성 돌발성 체위성 현기증 (BPPV) 시장예측 2021년-2026년

■ 영문 제목 : Global Benign Positional Vertigo Treatment Market Growth 2021-2026
	■ 상품코드 : LPI-2108K202113 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 130 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 양성 돌발성 체위성 현기증 (BPPV)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (항히스타민제, 항콜린제, 항우울제, 기타)와 용도별 시장규모 (소아병학, 성인병학, 노인병학) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 양성 돌발성 체위성 현기증 (BPPV) 시장 점유율
- 지역별 양성 돌발성 체위성 현기증 (BPPV) 시장규모
- 주요지역의 종류별 시장규모 (항히스타민제, 항콜린제, 항우울제, 기타)
- 주요지역의 용도별 시장규모 (소아병학, 성인병학, 노인병학)
- 미주의 양성 돌발성 체위성 현기증 (BPPV) 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 양성 돌발성 체위성 현기증 (BPPV) 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 양성 돌발성 체위성 현기증 (BPPV) 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 양성 돌발성 체위성 현기증 (BPPV) 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 양성 돌발성 체위성 현기증 (BPPV) 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Benign Positional Vertigo Treatment will have significant change from previous year. By the most conservative estimates of global Benign Positional Vertigo Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Benign Positional Vertigo Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Benign Positional Vertigo Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Anti-histamine
Anti-cholinergic
Anti-depressant
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pediatrics
Adults
Geriatrics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Sanofi
Medichem
LGM Pharma
AstraZeneca
Intas Pharmaceutical
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Marclabs

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Benign Positional Vertigo Treatment Consumption 2016-2026
2.1.2 Benign Positional Vertigo Treatment Consumption CAGR by Region
2.2 Benign Positional Vertigo Treatment Segment by Type
2.2.1 Anti-histamine
2.2.2 Anti-cholinergic
2.2.3 Anti-depressant
2.2.4 Others
2.3 Benign Positional Vertigo Treatment Sales by Type
2.3.1 Global Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
2.3.2 Global Benign Positional Vertigo Treatment Revenue and Market Share by Type (2016-2021)
2.3.3 Global Benign Positional Vertigo Treatment Sale Price by Type (2016-2021)
2.4 Benign Positional Vertigo Treatment Segment by Application
2.4.1 Pediatrics
2.4.2 Adults
2.4.3 Geriatrics
2.5 Benign Positional Vertigo Treatment Sales by Application
2.5.1 Global Benign Positional Vertigo Treatment Sale Market Share by Application (2016-2021)
2.5.2 Global Benign Positional Vertigo Treatment Revenue and Market Share by Application (2016-2021)
2.5.3 Global Benign Positional Vertigo Treatment Sale Price by Application (2016-2021)

3 Global Benign Positional Vertigo Treatment by Company
3.1 Global Benign Positional Vertigo Treatment Sales Market Share by Company
3.1.1 Global Benign Positional Vertigo Treatment Sales by Company (2019-2021)
3.1.2 Global Benign Positional Vertigo Treatment Sales Market Share by Company (2019-2021)
3.2 Global Benign Positional Vertigo Treatment Revenue Market Share by Company
3.2.1 Global Benign Positional Vertigo Treatment Revenue by Company (2019-2021)
3.2.2 Global Benign Positional Vertigo Treatment Revenue Market Share by Company (2019-2021)
3.3 Global Benign Positional Vertigo Treatment Sale Price by Company
3.4 Global Manufacturers Benign Positional Vertigo Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Positional Vertigo Treatment Product Location Distribution
3.4.2 Players Benign Positional Vertigo Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Benign Positional Vertigo Treatment by Region
4.1 Global Benign Positional Vertigo Treatment by Region
4.1.1 Global Benign Positional Vertigo Treatment Sales by Region
4.1.2 Global Benign Positional Vertigo Treatment Revenue by Region
4.2 Americas Benign Positional Vertigo Treatment Sales Growth
4.3 APAC Benign Positional Vertigo Treatment Sales Growth
4.4 Europe Benign Positional Vertigo Treatment Sales Growth
4.5 Middle East & Africa Benign Positional Vertigo Treatment Sales Growth

5 Americas
5.1 Americas Benign Positional Vertigo Treatment Sales by Country
5.1.1 Americas Benign Positional Vertigo Treatment Sales by Country (2016-2021)
5.1.2 Americas Benign Positional Vertigo Treatment Revenue by Country (2016-2021)
5.2 Americas Benign Positional Vertigo Treatment Sales by Type
5.3 Americas Benign Positional Vertigo Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Benign Positional Vertigo Treatment Sales by Region
6.1.1 APAC Benign Positional Vertigo Treatment Sales by Region (2016-2021)
6.1.2 APAC Benign Positional Vertigo Treatment Revenue by Region (2016-2021)
6.2 APAC Benign Positional Vertigo Treatment Sales by Type
6.3 APAC Benign Positional Vertigo Treatment Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Benign Positional Vertigo Treatment by Country
7.1.1 Europe Benign Positional Vertigo Treatment Sales by Country (2016-2021)
7.1.2 Europe Benign Positional Vertigo Treatment Revenue by Country (2016-2021)
7.2 Europe Benign Positional Vertigo Treatment Sales by Type
7.3 Europe Benign Positional Vertigo Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Benign Positional Vertigo Treatment by Country
8.1.1 Middle East & Africa Benign Positional Vertigo Treatment Sales by Country (2016-2021)
8.1.2 Middle East & Africa Benign Positional Vertigo Treatment Revenue by Country (2016-2021)
8.2 Middle East & Africa Benign Positional Vertigo Treatment Sales by Type
8.3 Middle East & Africa Benign Positional Vertigo Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Benign Positional Vertigo Treatment Distributors
10.3 Benign Positional Vertigo Treatment Customer

11 Global Benign Positional Vertigo Treatment Market Forecast
11.1 Global Benign Positional Vertigo Treatment Forecast by Region
11.1.1 Global Benign Positional Vertigo Treatment Forecast by Regions (2021-2026)
11.2.2 Global Benign Positional Vertigo Treatment Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Benign Positional Vertigo Treatment Forecast by Type
11.7 Global Benign Positional Vertigo Treatment Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Company Information
12.1.2 Pfizer Benign Positional Vertigo Treatment Product Offered
12.1.3 Pfizer Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Benign Positional Vertigo Treatment Product Offered
12.2.3 Sanofi Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofi Main Business Overview
12.2.5 Sanofi Latest Developments
12.3 Medichem
12.3.1 Medichem Company Information
12.3.2 Medichem Benign Positional Vertigo Treatment Product Offered
12.3.3 Medichem Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Medichem Main Business Overview
12.3.5 Medichem Latest Developments
12.4 LGM Pharma
12.4.1 LGM Pharma Company Information
12.4.2 LGM Pharma Benign Positional Vertigo Treatment Product Offered
12.4.3 LGM Pharma Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 LGM Pharma Main Business Overview
12.4.5 LGM Pharma Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Benign Positional Vertigo Treatment Product Offered
12.5.3 AstraZeneca Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Intas Pharmaceutical
12.6.1 Intas Pharmaceutical Company Information
12.6.2 Intas Pharmaceutical Benign Positional Vertigo Treatment Product Offered
12.6.3 Intas Pharmaceutical Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Intas Pharmaceutical Main Business Overview
12.6.5 Intas Pharmaceutical Latest Developments
12.7 Cadila Pharmaceuticals
12.7.1 Cadila Pharmaceuticals Company Information
12.7.2 Cadila Pharmaceuticals Benign Positional Vertigo Treatment Product Offered
12.7.3 Cadila Pharmaceuticals Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Cadila Pharmaceuticals Main Business Overview
12.7.5 Cadila Pharmaceuticals Latest Developments
12.8 Sun Pharmaceutical Industries
12.8.1 Sun Pharmaceutical Industries Company Information
12.8.2 Sun Pharmaceutical Industries Benign Positional Vertigo Treatment Product Offered
12.8.3 Sun Pharmaceutical Industries Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sun Pharmaceutical Industries Main Business Overview
12.8.5 Sun Pharmaceutical Industries Latest Developments
12.9 Marclabs
12.9.1 Marclabs Company Information
12.9.2 Marclabs Benign Positional Vertigo Treatment Product Offered
12.9.3 Marclabs Benign Positional Vertigo Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Marclabs Main Business Overview
12.9.5 Marclabs Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Benign Positional Vertigo Treatment Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Anti-histamine
Table 3. Major Players of Anti-cholinergic
Table 4. Major Players of Anti-depressant
Table 5. Major Players of Others
Table 6. Global Benign Positional Vertigo Treatment Sales by Type (2016-2021) & (K Units)
Table 7. Global Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
Table 8. Global Benign Positional Vertigo Treatment Revenue by Type (2016-2021) & ($ million)
Table 9. Global Benign Positional Vertigo Treatment Revenue Market Share by Type (2016-2021)
Table 10. Global Benign Positional Vertigo Treatment Sale Price by Type (2016-2021)
Table 11. Global Benign Positional Vertigo Treatment Sales by Application (2016-2021) & (K Units)
Table 12. Global Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Table 13. Global Benign Positional Vertigo Treatment Value by Application (2016-2021)
Table 14. Global Benign Positional Vertigo Treatment Revenue Market Share by Application (2016-2021)
Table 15. Global Benign Positional Vertigo Treatment Sale Price by Application (2016-2021)
Table 16. Global Benign Positional Vertigo Treatment Sales by Company (2019-2021) & (K Units)
Table 17. Global Benign Positional Vertigo Treatment Sales Market Share by Company (2019-2021)
Table 18. Global Benign Positional Vertigo Treatment Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Benign Positional Vertigo Treatment Revenue Market Share by Company (2019-2021)
Table 20. Global Benign Positional Vertigo Treatment Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Benign Positional Vertigo Treatment Producing Area Distribution and Sales Area
Table 22. Players Benign Positional Vertigo Treatment Products Offered
Table 23. Benign Positional Vertigo Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Benign Positional Vertigo Treatment Sales by Region (2016-2021) (K Units)
Table 27. Global Benign Positional Vertigo Treatment Sales Market Share by Region (2016-2021)
Table 28. Global Benign Positional Vertigo Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Benign Positional Vertigo Treatment Revenue Market Share by Region (2016-2021)
Table 30. Americas Benign Positional Vertigo Treatment Sales by Country (2016-2021) & (K Units)
Table 31. Americas Benign Positional Vertigo Treatment Sales Market Share by Country (2016-2021)
Table 32. Americas Benign Positional Vertigo Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Benign Positional Vertigo Treatment Revenue Market Share by Country (2016-2021)
Table 34. Americas Benign Positional Vertigo Treatment Sales by Type (2016-2021) & (K Units)
Table 35. Americas Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
Table 36. Americas Benign Positional Vertigo Treatment Sales by Application (2016-2021) & (K Units)
Table 37. Americas Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Table 38. APAC Benign Positional Vertigo Treatment Sales by Region (2016-2021) & (K Units)
Table 39. APAC Benign Positional Vertigo Treatment Sales Market Share by Region (2016-2021)
Table 40. APAC Benign Positional Vertigo Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Benign Positional Vertigo Treatment Revenue Market Share by Region (2016-2021)
Table 42. APAC Benign Positional Vertigo Treatment Sales by Type (2016-2021) & (K Units)
Table 43. APAC Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
Table 44. APAC Benign Positional Vertigo Treatment Sales by Application (2016-2021) & (K Units)
Table 45. APAC Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Table 46. Europe Benign Positional Vertigo Treatment Sales by Country (2016-2021) & (K Units)
Table 47. Europe Benign Positional Vertigo Treatment Sales Market Share by Country (2016-2021)
Table 48. Europe Benign Positional Vertigo Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Benign Positional Vertigo Treatment Revenue Market Share by Country (2016-2021)
Table 50. Europe Benign Positional Vertigo Treatment Sales by Type (2016-2021) & (K Units)
Table 51. Europe Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
Table 52. Europe Benign Positional Vertigo Treatment Sales by Application (2016-2021) & (K Units)
Table 53. Europe Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Benign Positional Vertigo Treatment Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Benign Positional Vertigo Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Benign Positional Vertigo Treatment Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Benign Positional Vertigo Treatment Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Benign Positional Vertigo Treatment Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Benign Positional Vertigo Treatment
Table 63. Key Application and Potential Industries of Benign Positional Vertigo Treatment
Table 64. Key Challenges of Benign Positional Vertigo Treatment
Table 65. Key Trends of Benign Positional Vertigo Treatment
Table 66. Benign Positional Vertigo Treatment Distributors List
Table 67. Benign Positional Vertigo Treatment Customer List
Table 68. Global Benign Positional Vertigo Treatment Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Benign Positional Vertigo Treatment Consumption Market Forecast by Region
Table 70. Global Benign Positional Vertigo Treatment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Benign Positional Vertigo Treatment Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Benign Positional Vertigo Treatment Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Benign Positional Vertigo Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Benign Positional Vertigo Treatment Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Benign Positional Vertigo Treatment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Benign Positional Vertigo Treatment Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Benign Positional Vertigo Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Benign Positional Vertigo Treatment Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Benign Positional Vertigo Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Benign Positional Vertigo Treatment Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Benign Positional Vertigo Treatment Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Benign Positional Vertigo Treatment Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Benign Positional Vertigo Treatment Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Benign Positional Vertigo Treatment Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Benign Positional Vertigo Treatment Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Benign Positional Vertigo Treatment Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Benign Positional Vertigo Treatment Revenue Market Share Forecast by Application (2021-2026)
Table 88. Pfizer Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Benign Positional Vertigo Treatment Product Offered
Table 90. Pfizer Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Sanofi Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Benign Positional Vertigo Treatment Product Offered
Table 95. Sanofi Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Medichem Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Medichem Benign Positional Vertigo Treatment Product Offered
Table 100. Medichem Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Medichem Main Business
Table 102. Medichem Latest Developments
Table 103. LGM Pharma Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. LGM Pharma Benign Positional Vertigo Treatment Product Offered
Table 105. LGM Pharma Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. LGM Pharma Main Business
Table 107. LGM Pharma Latest Developments
Table 108. AstraZeneca Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. AstraZeneca Benign Positional Vertigo Treatment Product Offered
Table 110. AstraZeneca Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. AstraZeneca Main Business
Table 112. AstraZeneca Latest Developments
Table 113. Intas Pharmaceutical Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Intas Pharmaceutical Benign Positional Vertigo Treatment Product Offered
Table 115. Intas Pharmaceutical Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Intas Pharmaceutical Main Business
Table 117. Intas Pharmaceutical Latest Developments
Table 118. Cadila Pharmaceuticals Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Cadila Pharmaceuticals Benign Positional Vertigo Treatment Product Offered
Table 120. Cadila Pharmaceuticals Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Cadila Pharmaceuticals Main Business
Table 122. Cadila Pharmaceuticals Latest Developments
Table 123. Sun Pharmaceutical Industries Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Sun Pharmaceutical Industries Benign Positional Vertigo Treatment Product Offered
Table 125. Sun Pharmaceutical Industries Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Sun Pharmaceutical Industries Main Business
Table 127. Sun Pharmaceutical Industries Latest Developments
Table 128. Marclabs Basic Information, Benign Positional Vertigo Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Marclabs Benign Positional Vertigo Treatment Product Offered
Table 130. Marclabs Benign Positional Vertigo Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. Marclabs Main Business
Table 132. Marclabs Latest Developments
List of Figures
Figure 1. Picture of Benign Positional Vertigo Treatment
Figure 2. Benign Positional Vertigo Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Positional Vertigo Treatment Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Benign Positional Vertigo Treatment Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Benign Positional Vertigo Treatment Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Anti-histamine
Figure 10. Product Picture of Anti-cholinergic
Figure 11. Product Picture of Anti-depressant
Figure 12. Product Picture of Others
Figure 13. Global Benign Positional Vertigo Treatment Sales Market Share by Type in 2020
Figure 14. Global Benign Positional Vertigo Treatment Revenue Market Share by Type (2016-2021)
Figure 15. Benign Positional Vertigo Treatment Consumed in Pediatrics
Figure 16. Global Benign Positional Vertigo Treatment Market: Pediatrics (2016-2021) & (K Units)
Figure 17. Benign Positional Vertigo Treatment Consumed in Adults
Figure 18. Global Benign Positional Vertigo Treatment Market: Adults (2016-2021) & (K Units)
Figure 19. Benign Positional Vertigo Treatment Consumed in Geriatrics
Figure 20. Global Benign Positional Vertigo Treatment Market: Geriatrics (2016-2021) & (K Units)
Figure 21. Global Benign Positional Vertigo Treatment Sales Market Share by Application (2016-2021)
Figure 22. Global Benign Positional Vertigo Treatment Revenue Market Share by Application in 2020
Figure 23. Benign Positional Vertigo Treatment Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Benign Positional Vertigo Treatment Revenue Market Share by Company in 2020
Figure 25. Global Benign Positional Vertigo Treatment Sales Market Share by Regions (2016-2021)
Figure 26. Global Benign Positional Vertigo Treatment Revenue Market Share by Region in 2020
Figure 27. Americas Benign Positional Vertigo Treatment Sales 2016-2021 (K Units)
Figure 28. Americas Benign Positional Vertigo Treatment Revenue 2016-2021 ($ Millions)
Figure 29. APAC Benign Positional Vertigo Treatment Sales 2016-2021 (K Units)
Figure 30. APAC Benign Positional Vertigo Treatment Revenue 2016-2021 ($ Millions)
Figure 31. Europe Benign Positional Vertigo Treatment Sales 2016-2021 (K Units)
Figure 32. Europe Benign Positional Vertigo Treatment Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Benign Positional Vertigo Treatment Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Benign Positional Vertigo Treatment Revenue 2016-2021 ($ Millions)
Figure 35. Americas Benign Positional Vertigo Treatment Sales Market Share by Country in 2020
Figure 36. Americas Benign Positional Vertigo Treatment Revenue Market Share by Country in 2020
Figure 37. Americas Benign Positional Vertigo Treatment Sales Market Share by Type in 2020
Figure 38. Americas Benign Positional Vertigo Treatment Sales Market Share by Application in 2020
Figure 39. United States Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Benign Positional Vertigo Treatment Sales Market Share by Region in 2020
Figure 44. APAC Benign Positional Vertigo Treatment Revenue Market Share by Regions in 2020
Figure 45. APAC Benign Positional Vertigo Treatment Sales Market Share by Type in 2020
Figure 46. APAC Benign Positional Vertigo Treatment Sales Market Share by Application in 2020
Figure 47. China Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Benign Positional Vertigo Treatment Sales Market Share by Country in 2020
Figure 54. Europe Benign Positional Vertigo Treatment Revenue Market Share by Country in 2020
Figure 55. Europe Benign Positional Vertigo Treatment Sales Market Share by Type in 2020
Figure 56. Europe Benign Positional Vertigo Treatment Sales Market Share by Application in 2020
Figure 57. Germany Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Benign Positional Vertigo Treatment Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Benign Positional Vertigo Treatment Sales Market Share by Application in 2020
Figure 66. Egypt Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Benign Positional Vertigo Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

※본 조사보고서 [세계의 양성 돌발성 체위성 현기증 (BPPV) 시장예측 2021년-2026년] (코드 : LPI-2108K202113) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 양성 돌발성 체위성 현기증 (BPPV) 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 안구 건조증 치료 시장예측 2021년-2026년
LPI-2108K200007 / LP Information / 2021년 8월 / 본 조사보고서는 안구 건조증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Dry Eye Syndrome Treatment will have significant change from previous year. By the most conservative estimates of global Dry Eye Syndrome Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2992.9...

세계의 운동 선수용 무릎 치료 시장예측 2021년-2026년
LPI-2108K202110 / LP Information / 2021년 8월 / 본 조사보고서는 운동 선수용 무릎 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Athletic Knee Treatment will have significant change from previous year. By the most conservative estimates of global Athletic Knee Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 요실금 치료 장치 시장예측 2021년-2026년
LPI-2108K200081 / LP Information / 2021년 8월 / 본 조사보고서는 요실금 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Urinary Incontinence Treatment Devices will have significant change from previous year. By the most conservative estimates of global Urinary Incontinence Treatment Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1901.1...

세계의 간질 치료 장치 시장예측 2021년-2026년
LPI-2108K201335 / LP Information / 2021년 8월 / 본 조사보고서는 간질 치료 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Epilepsy Treatment Device will have significant change from previous year. By the most conservative estimates of global Epilepsy Treatment Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 공기 처리 제품 시장예측 2021년-2026년
LPI-2108K202261 / LP Information / 2021년 8월 / 본 조사보고서는 공기 처리 제품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Air Treatment Products will have significant change from previous year. By the most conservative estimates of global Air Treatment Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 15320 million in...

세계의 유산소 치료 시스템 시장예측 2021년-2026년
LPI-2108K200494 / LP Information / 2021년 8월 / 본 조사보고서는 유산소 치료 시스템의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Aerobic Treatment Systems will have significant change from previous year. By the most conservative estimates of global Aerobic Treatment Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 여드름 치료제 시장예측 2021년-2026년
LPI-2108K202092 / LP Information / 2021년 8월 / 본 조사보고서는 여드름 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Acne Medication will have significant change from previous year. By the most conservative estimates of global Acne Medication market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 6748.3 million in 2019. Over...

세계의 사이클로스포린 시장예측 2021년-2026년
LPI-2108K200008 / LP Information / 2021년 8월 / 본 조사보고서는 사이클로스포린의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Cyclosporine will have significant change from previous year. By the most conservative estimates of global Cyclosporine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 베타히스틴 시장예측 2021년-2026년
LPI-2108K201117 / LP Information / 2021년 8월 / 본 조사보고서는 베타히스틴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Betahistine will have significant change from previous year. By the most conservative estimates of global Betahistine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...

세계의 칸시다스 시장예측 2021년-2026년
LPI-2108K201156 / LP Information / 2021년 8월 / 본 조사보고서는 칸시다스의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Cancidas will have significant change from previous year. By the most conservative estimates of global Cancidas market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next...